Use of Antipsychotic Medications in Pediatric Populations: What do the Data Say?-Reference-Cited by-同舟云学术

Use of Antipsychotic Medications in Pediatric Populations: What do the Data Say?

Published:2013-11-21 Issue:12 Volume:15 Page:
ISSN:1523-3812
Container-title:Current Psychiatry Reports
language:en
Short-container-title:Curr Psychiatry Rep

Author:

Penfold Robert B.,Stewart Christine,Hunkeler Enid M.,Madden Jeanne M.,Cummings Janet R.,Owen-Smith Ashli A.,Rossom Rebecca C.,Lu Christine Y.,Lynch Frances L.,Waitzfelder Beth E.,Coleman Karen A.,Ahmedani Brian K.,Beck Arne L.,Zeber John E.,Simon Gregory E.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11920-013-0426-8.pdf

Reference31 articles.

1. Olfson M, Crystal S, Huang C, Gerhard T. Trends in antipsychotic drug use by very young, privately insured children. J Am Acad Child Adolesc Psychiatry. 2010;49:13–23.

2. • Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69:1247–56. The article presents antipsychotic utilization estimates between 1993 and 2009 using nationally representative NAMCS data. Estimates are based on visits where a prescription occurred. Excellent discussion of reasons for practice variation in prescribing and increasing use over time.

3. • Andrade SE, Lo JC, Roblin D, Fouayzi H, Connor DF, Penfold RB, et al. Antipsychotic medication use among children and risk of diabetes mellitus. Pediatrics. 2011;128:1135–41. Study reports an almost fourfold increase in the rate of diabetes among youth using antipsychotic medications compared to youth using no psychotropic medications.

4. • Correll CU. Safety and tolerability of antipsychotic treatment in young patients with schizophrenia. J Clin Psychiatry. 2011;72:e26. Seminal study on the side effects of antipsychotic medications in youth.

5. • Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21:517–35. Review of 34 published head-to-head and placebo-controlled studies in youth with psychotic and bipolar disorders of the effects of antipsychotic medications on weight and metabolic disorders. Describes metabolic effects and number-needed-to-harm for individual agents.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Safer Use of Antipsychotics in Youth Study on Population Level Antipsychotic Initiation: An Interrupted Time Series Analysis;Journal of Child and Adolescent Psychopharmacology;2024-05-14

2. Antipsychotic prescribing: national findings of children and adolescents attending mental health services in Ireland;European Child & Adolescent Psychiatry;2024-04-12

3. Ten-year patterns of psychiatric medications dispensed to adolescent in Finland: Open dialogue-informed practice in Western Lapland as compared to practice in other Finnish regions;Personalized Medicine in Psychiatry;2024-03

4. Antipsychotic prescribing patterns in children and adolescents attending Australian general practice in 2011 and 2017;JCPP Advances;2023-11-10

5. Effectiveness of lifestyle interventions for improving the physical health of children and adolescents taking antipsychotic medications: protocol for a systematic review and meta-analysis;BMJ Open;2023-10